Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03590535 · ClinicalTrials.gov registry record
5th Generation cTnT in ED ACS
A clinical trial of Acute Coronary Syndrome, sponsored by Columbia University.
- Completed
- Registry status
- 1,949
- Enrollment target
- 1
- Study location
NCT03590535 is a study of Acute Coronary Syndrome that has completed, run by Columbia University. The registered enrollment target is 1,949 participants, below the 2,673-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03590535, a study of Acute Coronary Syndrome, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 1,949 participants
- Enrollment target
- 1
- Study location
Study Summary
This study intends to investigate the usefulness of the new "5th generation" cardiac troponin enzyme in determining which patients presenting with possible acute coronary syndrome can be quickly and safely discharged or admitted from the Emergency Department. The investigators hypothesize that introducing this enzyme into practice will reduce the time it takes to make decisions about admitting or discharging these patients with no increase in adverse events in the discharged patients.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST 4th Gen cTnT
- DIAGNOSTIC_TEST 5th Gen cTnT
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,949 participants |
| Start Date | 2018-09-24 |
| Est. Completion | 2020-06-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03590535
The ClinicalTrials.gov registry entry for NCT03590535 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,949 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,673-participant average among 40 other Acute Coronary Syndrome trials with a reported enrollment target (27% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Coronary Syndrome appearing as the primary indexed condition, and to 2 interventions - of which 4th Gen cTnT is the first listed.
NCT03590535 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03590535 about?
NCT03590535 is a clinical study titled "5th Generation cTnT in ED ACS". This study intends to investigate the usefulness of the new "5th generation" cardiac troponin enzyme in determining which patients presenting with possible acute coronary syndrome can be quickly and safely discharged or admitted from the Emergency Department. The investigators hypothesize that intro...
What is the current status of trial NCT03590535?
This trial is currently completed. The enrollment target is 1,949 participants. The study started on 2018-09-24. Estimated completion is 2020-06-07.
What conditions does trial NCT03590535 study?
This clinical trial studies the following conditions: Acute Coronary Syndrome.
What interventions are being tested in trial NCT03590535?
The interventions under investigation include: 4th Gen cTnT (DIAGNOSTIC_TEST), 5th Gen cTnT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03590535?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03590535 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Polypill for Acute Coronary Syndrome
RECRUITING · Phase 2
-
Positive Emotions Following Acute Cardiac Events
RECRUITING · NA
-
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
RECRUITING
-
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
RECRUITING · Phase 3
-
A Prospective Research Investigation of Ischemia Using MCG
RECRUITING
-
AngelMed Guardian® System PMA Post Approval Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.